I tend to agree in some extent. Though, to be fair, you have to...

I tend to agree in some extent. Though, to be fair, you have to take what they said about commenting on the approval process on face value. Imagine the backlash if they had jeopardised the approval by speaking about something out of turn.

The one thing that has been significantly absent the last couple of years has been their attendance at conferences and the like. They used to be all over that, touting the benefits of the product to all and sundry. I hope they've been keeping the awareness of the product up in the woundcare community.